PREVENTION OF GLOMERULAR HYPERTROPHY AND GLOMERULOSCLEROSIS IN MILAN NORMOTENSIVE RATS BY LOW-PROTEIN DIET, BUT NOT BY LOW-DOSE CAPTOPRIL TREATMENT

被引:5
作者
KLIEM, V [1 ]
BRUNKHORST, R [1 ]
EHLERDING, G [1 ]
KUHN, K [1 ]
NEUMANN, KH [1 ]
KOCH, KM [1 ]
机构
[1] KLINIKUM KARLSRUHE,DEPT INTERNAL MED,DIV NEPHROL & RHEUMATOL,KARLSRUHE,GERMANY
来源
NEPHRON | 1995年 / 71卷 / 02期
关键词
CAPTOPRIL; GLOMERULAR HYPERTROPHY; GLOMERULOSCLEROSIS; LOW-PROTEIN DIET; MILAN NORMOTENSIVE RATS;
D O I
10.1159/000188714
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Milan normotensive rats, which spontaneously develop marked proteinuria (PU) and glomerulosclerosis (GS), were either kept on a normal-protein diet, a normal-protein diet with additional low-dose captopril (CAP), which did not affect blood pressure, or on a low-protein diet. After 8 months PU (79 +/- 25 mg/day) GS (3 +/- 2%) and total glomerular volume (TGV; 27.9 +/- 2.9 mm(3)/kidney) were significantly lower (p < 0.05) in the low-protein diet group than in both the normal-protein group (PU 583 +/- 210 mg/day, GS 12 +/- 5%, TGV 34.6 +/- 8 mm(3)/kidney) and the low-CAP group (PU 611 +/- 224 mg/day, GS 16 +/- 6%, TGV 41.8 +/- 8.6 mm(3)/kidney). In conclusion, the development of glomerular hypertrophy and GS in Milan normotensive rats was reduced by the low-protein diet, but not by low-CAP treatment.
引用
收藏
页码:208 / 212
页数:5
相关论文
共 37 条
[1]   THERAPEUTIC ADVANTAGE OF CONVERTING ENZYME-INHIBITORS IN ARRESTING PROGRESSIVE RENAL-DISEASE ASSOCIATED WITH SYSTEMIC HYPERTENSION IN THE RAT [J].
ANDERSON, S ;
RENNKE, HG ;
BRENNER, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) :1993-2000
[2]  
BERTANI T, 1982, LAB INVEST, V46, P16
[3]   CONVERTING ENZYME-INHIBITION AND PROGRESSIVE GLOMERULOSCLEROSIS IN THE RAT [J].
BEUKERS, JJB ;
VANDERWAL, A ;
HOEDEMAEKER, PJ ;
WEENING, JJ .
KIDNEY INTERNATIONAL, 1987, 32 (06) :794-800
[4]   DEVELOPMENT OF A NEW STRAIN OF SPONTANEOUSLY HYPERTENSIVE RATS [J].
BIANCHI, G ;
FOX, U ;
IMBASCIATI, E .
LIFE SCIENCES, 1974, 14 (02) :339-347
[5]  
Bianchi G., 1984, HDB HYPERTENSION, V4, P328
[6]  
BOLTON WK, 1976, AM J PATHOL, V85, P277
[7]  
BRANDIS A, 1986, LAB INVEST, V55, P234
[8]  
BRENNER BM, 1982, NEW ENGL J MED, V307, P652, DOI 10.1056/NEJM198209093071104
[9]  
COUSER WG, 1975, LAB INVEST, V33, P491
[10]  
DIAMOND JR, 1986, AM J PATHOL, V122, P481